It’s big news when global businesses decide to find a permanent home in the United States. Not only do local economies rejoice, but so does all of American manufacturing. When that business has a goal of advancing cancer diagnosis and therapies, it’s even better. Isotopia Nuclear Medicine has recently announced a partnership to build its first manufacturing facility in the United States.
Isotopia USA
The Israeli based company, Isotopia Nuclear Medicine (Isotopia Global) was established as Isotopia Molecular Imaging in 2007 by a collaboration of scientists and radiopharmacists. Their fore-running product is a therapeutic radioactive isotope, Lutetium-177. In layman’s terms, it’s a type of nuclear medicine used to treat late-stage cancers. This product, among other products and services, remains a strong focal point of the company today.
Isotopia continues to supply its market with radioactive isotopes and cold kits, necessary equipment in the oncology fields. On top of physical product supply, the company also offers expert support services. Due to a rising global demand, they are extending their footprint to North America and Europe.
American Footprint
Istotopia Global added its American branch, Isotopia USA, in 2023. The American sector will invest $20 million in the build-out of its new manufacturing facility, to be located in Westfield, Indiana. This plant is expected to create at least 50 high-paying jobs and begin manufacturing medicines by the end of 2024.
According to Indiana Secretary of Commerce David Rosenberg, “Indiana’s life sciences sector continues to grow, generating a $79 billion economic impact and providing life-hanging products, pharmaceuticals, and medical devices to customers around the world.” With this, the state gladly welcomes the addition of Isotopia USA to its roster.
To support the company’s move to its first US manufacturing site, Indiana has offered investments, tax incentives, and other fiscal support totaling over $2.5 million. Furthermore, Isotopia USA just announced a new partnership with E Solutions and Comfort Systems USA to help build and establish their new facility over the next 12 months.
American Partnership
E Solutions, a subsidiary of Comfort Systems USA, is a supplier of clean rooms, shielded isolators, and hot cells. Comfort Systems USA conducts standard mechanical/electrical/plumbing construction. They’ll be working with Isotopia USA to build 28,000 square feet of clean rooms and laboratories at their new site in Indiana.
Greg Bielefeild, the President of E Solutions, stated enthusiasm for the new partnership, referring to Isotopia USA as “…an industry leader in the production of cancer treatments, and we cannot be more proud to support them in their endeavor.”
Comfort Systems USA has been a public company since 1997 and operates over 170 locations across the nation. They house 45 divisions, including local branches and trade specialists like E Solutions.
Isotopia USA’s Roadmap Forward
With hearty support and partnership to accelerate the new Isotopia USA manufacturing facility, the schedule remains as predicted. Isotopia will begin producing and delivering its chemotherapy product this year, while the construction continues into 2025. Full operations and employee hiring is projected to be complete by 2027.
Soon, Indiana will host a newly completed nuclear medicine facility, built from American hands, powered by American scientists, and delivered to American patients. Over 17 million people live with cancer in the United States. Welcoming a state-of-the-art diagnosis and therapy provider is a smart move, to say the least. Nuclear maneuvering is not for the faint of heart. That’s why it makes perfect sense for it to happen here in the United States.
